Italy· 039855022
MANIDIPINA*28 cpr 20 mg
A medicinal product containing manidipina, registered in Italy by SANDOZ SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Manidipina
- Manufacturer
- SANDOZ SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic039855022MANIDIPINA*28 cpr 20 mgEUR 11.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Manidipina in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainARTEDIL 10 mg COMPRIMIDOSChiesi España S.A.U.
- FranceIPERTEN 10 mg, compriméCHIESI
- United KingdomIperten 10mg tabletsImported (France)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Artedil, Manidipino Aurovitas
- France · Iperten, Manidipine Arrow
- Greece · Manyper, Presidin
- Portugal · Manidipina Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f96436c-c5ef-4bff-87c6-e4c1e92c5c0b GET /v1/drugs/8f96436c-c5ef-4bff-87c6-e4c1e92c5c0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 11.33,
"source": "aifa",
"currency": "EUR",
"strength": "MANIDIPINA 20MG 28 UNITA' USO ORALE",
"substance": "Manidipina",
"equivalence_group": "F9A",
"transparency_flag": "X"
}See everything about manidipina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.